Graphium biosciences inc
WebMay 13, 2024 · We now have the requisite capital to further advance our ESG-centric mission of creating a market-leading environmental services business that improves the health and wellness of our planet, with a... WebApr 1, 2024 · Its Graphium Biosciences, Inc. is focused on advancing its portfolio of over 100 cannabinoid-glycoside compounds created using its enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions. The Daedalus Ecosciences, Inc. (Daedalus). is focused on the health and wellness through …
Graphium biosciences inc
Did you know?
WebOct 26, 2024 · Type: Grant Filed: September 22, 2016 Date of Patent: December 28, 2024 Assignee: Graphium Biosciences, Inc. Inventors: Brandon J. Zipp, Janee M. Hardman, …
WebOct 12, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel … cleveland, ohio, may 13, 2024 (globe newswire) -- malachite innovations, inc. … GlobeNewswire specializes in the distribution and delivery of press … CLEVELAND, OHIO, Dec. 28, 2024 (GLOBE NEWSWIRE) -- MALACHITE … GlobeNewswire specializes in the distribution and delivery of press … June 26, 2024 11:00 ET Source: SPR Therapeutics, Inc. CLEVELAND, June … February 24, 2024 18:46 ET Source: We The Patriots USA, Inc. AKRON, Ohio, … WebInvestors. Graphium Biosciences. News and Events. 2024 ANNUAL REPORT HIGHLIGHTS. CLEVELAND, OHIO – (April 5, 2024) – MALACHITE INNOVATIONS, …
WebApr 6, 2024 · Malachite Innovations, Inc. FY 2024 revenue was $4.8 million compared to $0 of revenue reported for the four calendar yea... Malachite Innovations FY22 Revenue Grows To $4.8M, Achieving More Than Its Total Revenue Over Its Previous 10 Years Of … WebI n October 2024, the Company reorganized its corporate structure and created the following two wholly-owned operating subsidiaries: (i) Graphium Biosciences, Inc., a Nevada …
WebGraphium Biosciences, Inc. is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to October 2011 through two predecessor ...
WebLatest Graphium Biosciences, Inc. Patents: CANNABINOID GLYCOSIDES AND USES THEREOF CANNABINOID GLYCOSIDE PRODRUGS AND METHODS OF … grants pass northridge homesWebApr 6, 2024 · Graphium Biosciences, Inc. is a cannabinoid-based drug development company tracing its history of technological innovation and drug advancement back to … chipmunk\u0027s 6sWebOct 12, 2024 · Graphium Biosciences, our operating subsidiary dedicated to improving the health and wellness of people, seeks to advance our broad portfolio of over 100 novel cannabinoid-glycoside compounds created using our proprietary enzymatic bioprocessing technologies to develop safe and effective novel treatments for chronic and debilitating … chipmunk\u0027s 6tWebApr 6, 2024 · 40. Free-Float. 52,6%. More Financials. Company. Malachite Innovations, Inc. is a holding company, which operates through its subsidiaries Graphium Biosciences, Inc. and Daedalus Ecosciences, Inc. The Company focuses on improving the health and wellness of people and the planet. Its segments include Therapeutic Operations and … chipmunk\u0027s 6xWebApr 5, 2024 · Graphium Biosciences, Inc. ("Graphium") is a cannabinoid-based drug development company tracing its history of technological innovation and drug … grants pass land for saleWebMar 31, 2024 · Its Graphium Biosciences, Inc. is focused on advancing its portfolio of over 100 cannabinoid-glycoside compounds created using its enzymatic bioprocessing technologies to develop treatments for chronic and debilitating conditions. Daedalus Ecosciences, Inc. (Daedalus). is focused on the health and wellness through … chipmunk\u0027s 6wWebMar 27, 2024 · VITALITY BIOPHARMA INC. Malachite Innovations, Inc. is a holding company, which operates through its subsidiaries Graphium Biosciences, Inc. and Daedalus Ecosciences, Inc. The Company focuses on improving the health and wellness of people and the planet. Its segments include Therapeutic Operations and ESG Operations. chipmunk\u0027s 6y